The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome
Abstract
Low-dose dexamethasone suppression testing has been recommended for biochemical screening when Cushing's syndrome is suspected. The criterion for normal suppression of cortisol after dexamethasone is controversial. To assess diagnostic utility (sensitivity), we report the results of low-dose dexamethasone suppression testing in 103 patients with spontaneous Cushing's syndrome. There were 80 patients with Cushing's disease (78%), 13 with the ectopic ACTH syndrome (13%), and 10 with cortisol-producing adrenocortical adenomas (10%). Fourteen (18%) of 80 patients with Cushing's disease suppressed serum cortisol to less than 5 micro g/dl (<135 nmol/liter) after the overnight 1-mg test, whereas six patients (8%) actually showed suppression of serum cortisol to less than 2 micro g/dl (<54 nmol/liter). In addition, the 2-d, low-dose dexamethasone suppression test yielded false-negative results in 38% of patients when urine cortisol was used and 28% when urinary 17-hydroxycorticosteroids were used. Serum cortisol after the 1-mg test correlated with baseline urinary free cortisol (r = 0.705, P < 0.001), plasma ACTH level (r = 0.322, P = 0.001), and urinary free cortisol after the 2-d test (r = 0.709, P = 0.001). This study provides evidence that low-dose dexamethasone may suppress either plasma cortisol or urinary steroids to levels previously thought to exclude Cushing's syndrome and that these tests should not be used as the sole criterion to exclude the diagnosis of endogenous hypercortisolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because some patients with Cushing's disease demonstrate suppressibility to dexamethasone, use of this diagnostic criterion misclassified up to 15% of such patients as negative (81,82).”
From The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008) · cites this paper as [81]
In the citing paper
“Therefore, they may fail to detect cyclical CS during a low-cortisol phase (“off-cycle”) (a form of CS marked by intermittent cortisol excess) and may also yield normal or borderline results in patients with mild CS who have lower or fluctuating cortisol secretion (73, 90-93).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [73]
Citations
Cites
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationTauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Cushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393
Diagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336
Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8277 · Cited by 322
The Cushing Syndrome: An Update on Diagnostic Tests
Kaye, T. B., & Crapo, L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-434 · Cited by 310
Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou, D. A., Mullen, N., Kyrou, I., & Nieman, L. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020534 · Cited by 241
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell‐Price, J., Trainer, P., Perry, L., Wass, J., Grossman, A., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 229
Aron, D. C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1780 · Cited by 226
Self-citation
Cited by
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“misclassified up to 15% of such patients as negative (81, 82).”
BackgroundSelf-citationAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“The presence of atypical presentations in Cushing’s syndrome including those seen in PCOS and pseudo-Cushing’s should alert the endocrinologist to carefully evaluate any woman with PCOS who have developed some of the features seen in Cushing’s syndrome, other than menstrual dysfunction and hyperandrogenism (281, 282).”
BackgroundNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
“26”
Self-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Metadata
- Authors
- Findling, J. W., Raff, H., & Aron, D. C.
- Affiliations
- Medical College of Wisconsin (US)
- Louis Stokes Cleveland VA Medical Center (US)
- Corresponding author
- Findling, James W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1222-1226
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165331817
- Semantic Scholar
- cffdec9ae0a9b75b511f9282c64f18235ed6715a
- Cited by
- 165
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 2 · 2019: 5 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 12 · 2012: 5
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- low-dose dexamethasone suppression test, Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, endogenous hypercortisolism, diagnostic sensitivity, false-negative results, urinary free cortisol, urinary 17-hydroxycorticosteroids, ACTH
- MeSH terms
- Adult, Aged, Cushing Syndrome, Dexamethasone, Glucocorticoids, Humans, Hydrocortisone, Mass Screening, Sensitivity and Specificity, 17-Hydroxycorticosteroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. https://app.cochat.ai/papers/10.1210/jc.2003-030207
- The paper
- Findling, J. W., Raff, H., & Aron, D. C. (2004). The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.